zfn modified cd4+ t cells
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2009 (NCT00842634)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- T-lymphocytesSupplementation
T-lymphocytes supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- zfn modified cd4+ t cells
- zfn modified t cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02388594 | Phase 1 | Feb 1, 2015 | National Institute of Allergy and Infectious Diseases (NIAID), University of Pennsylvania |
| NCT00842634 | Phase 1 | Jan 1, 2009 | Sangamo BioSciences, University of Pennsylvania, Yeshiva University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Pennsylvania | Academic/Hospital | 2 | 2 | 1 | 2009 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 0 | 1 | 2015 |
| Sangamo BioSciences | For profit | 1 | 0 | 1 | 2009 |
| Yeshiva University | Academic/Hospital | 1 | 0 | 1 | 2009 |
4 organizations
Page 1 / 1